Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul P Belliveau

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medgenmed : Medscape General Medicine|December 22, 2005
Omalizumab: a monoclonal anti-IgE antibodyPaul P Belliveau
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Evaluation of omalizumab from a health plan perspectivePaul P Belliveau, Monina R Lahoz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2007
Emergence of fluoroquinolone only-resistant Escherichia coli in a community hospitalRocco J Perla, Eric L Knutson, Paul P Belliveau
The Annals of Pharmacotherapy|August 11, 2011
Boceprevir: a protease inhibitor for the treatment of chronic hepatitis CBryce S Foote, Linda M Spooner, Paul P Belliveau
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 2, 2003
Guidelines for liposomal amphotericin BJennifer L Mazzola, Paul P Belliveau, Sarah H Cheeseman
The Annals of Pharmacotherapy|July 7, 2011
Tigecycline for the treatment of severe Clostridium difficile infectionKelly C Larson, Paul P Belliveau, Linda M Spooner
The Annals of Pharmacotherapy|September 10, 2009
Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infectionMonica M Gaffney, Paul P Belliveau, Linda M Spooner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 6, 2009
Elevated creatine phosphokinase levels associated with linezolid therapyGlenn W Allison, Rocco J Perla, Paul P Belliveau, et al.
The Annals of Pharmacotherapy|November 22, 2013
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mLPatrick M McDaneld, Linda M Spooner, John F Mohr, et al.
The Annals of Pharmacotherapy|March 9, 2021
Transthyretin Amyloid Cardiomyopathy-Current and Future TherapiesJankhna D Yadav, Harjot Othee, Kelly A Chan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medgenmed : Medscape General Medicine|December 22, 2005
Omalizumab: a monoclonal anti-IgE antibodyPaul P Belliveau
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Evaluation of omalizumab from a health plan perspectivePaul P Belliveau, Monina R Lahoz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2007
Emergence of fluoroquinolone only-resistant Escherichia coli in a community hospitalRocco J Perla, Eric L Knutson, Paul P Belliveau
The Annals of Pharmacotherapy|August 11, 2011
Boceprevir: a protease inhibitor for the treatment of chronic hepatitis CBryce S Foote, Linda M Spooner, Paul P Belliveau
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 2, 2003
Guidelines for liposomal amphotericin BJennifer L Mazzola, Paul P Belliveau, Sarah H Cheeseman
The Annals of Pharmacotherapy|July 7, 2011
Tigecycline for the treatment of severe Clostridium difficile infectionKelly C Larson, Paul P Belliveau, Linda M Spooner
The Annals of Pharmacotherapy|September 10, 2009
Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infectionMonica M Gaffney, Paul P Belliveau, Linda M Spooner
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 6, 2009
Elevated creatine phosphokinase levels associated with linezolid therapyGlenn W Allison, Rocco J Perla, Paul P Belliveau, et al.
The Annals of Pharmacotherapy|November 22, 2013
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mLPatrick M McDaneld, Linda M Spooner, John F Mohr, et al.
The Annals of Pharmacotherapy|March 9, 2021
Transthyretin Amyloid Cardiomyopathy-Current and Future TherapiesJankhna D Yadav, Harjot Othee, Kelly A Chan, et al.
Pageof 2